Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
| Cat.No. | Product Name | Price |
|---|---|---|
| CSC-DC002260 | Panoply™ Human CACNA1I Knockdown Stable Cell Line | Inquiry |
| CSC-SC002260 | Panoply™ Human CACNA1I Over-expressing Stable Cell Line | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| AD02881Z | Human CACNA1I adenoviral particles | Inquiry |
| LV07712L | human CACNA1I (NM_021096) lentivirus particles | Inquiry |
| LV07713L | human CACNA1I (NM_001003406) lentivirus particles | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| SHH253345 | shRNA set against Human CACNA1I (NM_021096.3) | Inquiry |
| SHG131407 | shRNA set against Human CACNA1I(NM_001003406.1) | Inquiry |
| SHG131443 | shRNA set against Mouse Cacna1i(NM_001044308.2) | Inquiry |
| SHG131461 | shRNA set against Human CACNA1I(NM_021096.3) | Inquiry |
| SHG131489 | shRNA set against Rat Cacna1i(NM_020084.3) | Inquiry |
| SHH253349 | shRNA set against Mouse CACNA1I (NM_001044308.2) | Inquiry |
| SHH253353 | shRNA set against Rat CACNA1I (NM_020084.3) | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| OE-PNDC000346 | Human CACNA1I Nanodisc | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| CDFG003199 | Human CACNA1I cDNA Clone(NM_021096.3) | Inquiry |
| CDFG018584 | Mouse Cacna1i cDNA Clone(NM_001044308.2) | Inquiry |
| CDFH002570 | Human CACNA1I cDNA Clone(NM_001003406.1) | Inquiry |
| CDFR011645 | Rat Cacna1i cDNA Clone(NM_020084.3) | Inquiry |
| MiUTR1H-01597 | CACNA1I miRNA 3'UTR clone | Inquiry |
| MiUTR1M-02432 | CACNA1I miRNA 3'UTR clone | Inquiry |
| CDCB181721 | Rabbit CACNA1I ORF clone (XM_008257052.1) | Inquiry |
| CDCR233741 | Mouse Cacna1i ORF Clone(NM_001044308.2) | Inquiry |
| CDCR306589 | Human CACNA1I ORF Clone(NM_021096.3) | Inquiry |
| CDCR338856 | Human CACNA1I ORF Clone(NM_001003406.1) | Inquiry |
| CDCR378692 | Rat Cacna1i ORF Clone(NM_020084.3) | Inquiry |